What is the recommended treatment for influenza symptoms and cough?

Treatment of Influenza Symptoms and Cough

Start antiviral treatment with oseltamivir as soon as possible if you are hospitalized, have severe/progressive illness, are at high risk for complications (including age <2 or ≥65 years, pregnancy, chronic medical conditions, immunocompromised), and do not routinely use antibiotics unless bacterial coinfection is suspected. 1

Who Should Receive Antiviral Treatment

The decision to treat depends on your clinical presentation and risk factors:

Mandatory Treatment Groups (Start Immediately)

• Any hospitalized patient with documented or suspected influenza, regardless of illness duration 1
• Severe or progressive illness at any age, regardless of when symptoms started 1
• High-risk patients including:
  • Children under 2 years and adults ≥65 years 1
  • Pregnant women and up to 2 weeks postpartum 1
  • Chronic medical conditions (diabetes, heart disease, lung disease, etc.) 1
  • Immunocompromised patients 1

Optional Treatment

• Otherwise healthy outpatients without high-risk features can be considered for treatment, though the benefit is modest (approximately 24-hour reduction in illness duration) 2

Antiviral Medication Regimen

Use a single neuraminidase inhibitor for 5 days 1:

• Oseltamivir (oral) - First-line choice for most patients, especially severe illness 1, 3
• Zanamivir (inhaled) - Alternative option 1
• Peramivir (IV, single dose) - For patients unable to take oral/inhaled medications 1
• Baloxavir - Conditionally recommended for high-risk patients with non-severe illness 3, 4

Critical timing: Greatest benefit occurs when started within 24 hours of symptom onset, though treatment should be initiated within 48 hours whenever possible 1, 5, 2. For hospitalized or severely ill patients, start treatment immediately regardless of symptom duration 1.

Do not use combination therapy with multiple neuraminidase inhibitors or higher-than-approved doses 1.

Cough and Symptom Management

What NOT to Use

Strong recommendation against antibiotics for uncomplicated influenza without evidence of bacterial coinfection 3, 4. This is a critical stewardship point - antibiotics do not treat viral illness and contribute to resistance.

Conditional recommendations against in severe influenza 3, 4:

• Corticosteroids
• Macrolide antibiotics (unless bacterial coinfection confirmed)
• mTOR inhibitors
• NSAIDs (for anti-inflammatory purposes)
• Passive immune therapy

When to Add Antibiotics

Empirically treat for bacterial coinfection only when 1:

• Patient presents with severe disease initially (extensive pneumonia, respiratory failure, hypotension)
• Patient deteriorates after initial improvement
• Patient fails to improve after 3-5 days of antiviral treatment

Special Considerations for Immunocompromised or Hospitalized Patients

Consider longer duration of antiviral treatment beyond 5 days for 1:

• Documented or suspected immunocompromising conditions
• Severe lower respiratory tract disease (pneumonia, ARDS)
• Evidence of persistent viral replication

Common Pitfalls to Avoid

1. Delaying treatment while awaiting test results - Start antivirals based on clinical suspicion in high-risk patients 1
2. Prescribing antibiotics reflexively - Only use when bacterial coinfection is suspected based on clinical criteria 1, 3
3. Stopping antivirals too early in immunocompromised patients who may have prolonged viral shedding 1
4. Missing the treatment window - The 48-hour window is not absolute for severe cases; treat hospitalized patients regardless of symptom duration 1

Prophylaxis for Exposed Contacts

For asymptomatic persons exposed to seasonal influenza who are at very high risk of hospitalization, conditionally recommend prophylaxis with baloxavir, oseltamivir, zanamivir, or laninamivir 3, 4. For zoonotic influenza exposure, prophylaxis is recommended regardless of individual risk 3, 4.